Nab-paclitaxel Plus Gemcitabine as First-line Therapy for Cisplatin-ineligible or Cisplatin-incurable Advanced Urothelial Carcinoma
- Status
- TERMINATED
- Phase
- PHASE2
Clinical Trials Related to Urothelial Carcinoma
Related studies linked through entity extraction aliases.
Neoadjuvant Nivolumab With and Without Urelumab in Cisplatin-Ineligible or Chemotherapy-refusing Patients With Muscle-Invasive Urothelial Carcinoma of the Bladder
- Status
- ACTIVE_NOT_RECRUITING
- Phase
- PHASE2
Study of Atezolizumab as Monotherapy and in Combination With Platinum-Based Chemotherapy in Participants With Untreated Locally Advanced or Metastatic Urothelial Carcinoma
- Status
- COMPLETED
- Phase
- PHASE3
Study Assessing Activity of Molecularly Matched Targeted Therapies in Select Tumor Types Based on Genomic Alterations
- Status
- COMPLETED
- Phase
- PHASE2
Genomic Based Assignment of Therapy in Advanced Urothelial Carcinoma
- Status
- COMPLETED
- Phase
- PHASE2
Trial of EP0057, a Nanoparticle Camptothecin With Olaparib in People With Relapsed/Refractory Small Cell Lung Cancer
- Status
- COMPLETED
- Phase
- PHASE1/PHASE2
Multicohort Phase II Trial of sEphB4-HSA+Pembrolizumab in Solid Tumors
- Status
- ACTIVE_NOT_RECRUITING
- Phase
- PHASE2
The Cxbladder Monitoring Study
- Status
- COMPLETED
- Phase
- N/A
A Trial With Vinflunine in Patients With Metastatic Bladder Cancer and Impaired Renal Function
- Status
- COMPLETED
- Phase
- PHASE2
UC-GENOME: Urothelial Cancer-GENOmic Analysis to iMprove Patient Outcomes and rEsearch
- Status
- COMPLETED
- Phase
- NA
An Expanded Access Study of Atezolizumab in Participants With Locally Advanced or Metastatic Urothelial Carcinoma After Failure With Platinum-Containing Chemotherapy
- Status
- APPROVED_FOR_MARKETING
- Phase
- N/A
Whey Protein Supplement in Combination With Physical Exercise and Nutrition Program
- Status
- COMPLETED
- Phase
- NA
A Dose Escalation Study Of PF-06801591 In Melanoma, Head And Neck Cancer (SCCHN), Ovarian, Sarcoma, Non-Small Cell Lung Cancer, Urothelial Carcinoma or Other Solid Tumors
- Status
- COMPLETED
- Phase
- PHASE1
Study of Tipifarnib in Patients With Previously-Treated, Advanced, HRAS Mutant Urothelial Carcinoma
- Status
- UNKNOWN
- Phase
- PHASE2
Testing the PD-1 Inhibitor Pembrolizumab as Maintenance Therapy After Initial Chemotherapy in Metastatic Bladder Cancer
- Status
- COMPLETED
- Phase
- PHASE2
Study of the CD40 Agonistic Monoclonal Antibody APX005M
- Status
- COMPLETED
- Phase
- PHASE1
A Study of BIND-014 in Patients With Urothelial Carcinoma, Cholangiocarcinoma, Cervical Cancer and Squamous Cell Carcinoma of the Head and Neck
- Status
- TERMINATED
- Phase
- PHASE2
Safety Study of Enoblituzumab (MGA271) in Combination With Pembrolizumab or MGA012 in Refractory Cancer
- Status
- COMPLETED
- Phase
- PHASE1
A Study of Ramucirumab (LY3009806) Plus Docetaxel in Participants With Urothelial Cancer
- Status
- COMPLETED
- Phase
- PHASE3
Neoadjuvant Pembrolizumab in Combination With Gemcitabine Therapy in Cis-eligible/Ineligible UC Subjects
- Status
- COMPLETED
- Phase
- PHASE1/PHASE2